Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $448.16 million. The enterprise value is $76.06 million.

Market Cap	448.16M
Enterprise Value	76.06M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 37.44 million shares outstanding.

Current Share Class	37.44M
Shares Outstanding	37.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-4.97%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	59.75%
Float	22.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.24
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 30.03, with a Debt / Equity ratio of 0.00.

Current Ratio	30.03
Quick Ratio	29.78
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-81.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-31.06%
Revenue Per Employee	n/a
Profits Per Employee	-$2.87M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-66.54%
50-Day Moving Average	10.37
200-Day Moving Average	17.17
Relative Strength Index (RSI)	53.89
Average Volume (20 Days)	159,467

Short Selling Information

The latest short interest is 2.76 million, so 7.37% of the outstanding shares have been sold short.

Short Interest	2.76M
Short Previous Month	2.72M
Short % of Shares Out	7.37%
Short % of Float	12.18%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.48M
Pretax Income	n/a
Net Income	-80.35M
EBITDA	n/a
EBIT	-113.48M
Earnings Per Share (EPS)	-$3.04

Balance Sheet

The company has $349.09 million in cash and $947,000 in debt, giving a net cash position of $372.10 million or $9.94 per share.

Cash & Cash Equivalents	349.09M
Total Debt	947,000
Net Cash	372.10M
Net Cash Per Share	$9.94
Equity (Book Value)	364.73M
Book Value Per Share	9.66
Working Capital	340.36M

Cash Flow

In the last 12 months, operating cash flow was -$83.80 million and capital expenditures -$219,182, giving a free cash flow of -$84.02 million.

Operating Cash Flow	-83.80M
Capital Expenditures	-219,182
Free Cash Flow	-84.02M
FCF Per Share	-$2.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-17.93%
FCF Yield	-18.75%

Analyst Forecast

The average price target for ORKA is $39.71, which is 229.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.71
Price Target Difference	229.27%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	0.083333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a